Skip to content
Clinical Trials – home
Therapeutic area

Eye disorders – page 8

  • 373 clinical trials
  • 123 recruiting
  • 138 conditions
  • 27 countries

Conditions in this area

138 conditions with trials, the busiest first

Clinical trials in Eye disorders

373 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

373 clinical trials

Cataract

Recruiting

Study on Reducing Inflammation After Cataract Surgery Using Nepafenac and Dexamethasone for Patients Undergoing Surgery

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Oslo University Hospital HF
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Povidone
  • Sponsor:Centre Hospitalier Universitaire De Rennes

Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Oslo University Hospital HF

Study on Insulin Eye Drops for Treating Persistent Corneal Epithelial Defect in Patients with Neurotrophic or Chronic Ocular Surface Diseases

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Human
  • Sponsor:Hospital Clinico San Carlos

Study on Steroid and Rivaroxaban Treatment for Deep Vein Thrombosis in Behçet's Syndrome Patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rivaroxaban
  • Sponsor:Assistance Publique Hopitaux De Paris

Glaucoma

Recruiting

Study on the Effects of Semaglutide for Patients with Glaucoma

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Rigshospitalet

Study on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Janssen Cilag International

Study Comparing Two Prednisone Treatment Plans for Patients with Giant Cell Arteritis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Centre Hospitalier Universitaire De Caen Normandie

Study on Tinlarebant for Treating Geographic Atrophy in Patients

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Tinlarebant
  • Sponsor:Belite Bio Inc.

Glaucoma

Recruiting

Study Comparing Lidocaine Gel and Tetracaine/Oxybuprocaine Eye Drops for Glaucoma Patients Undergoing Outpatient Needling Procedures

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Lidocaine Hydrochloride
  • Sponsor:Hospital Universitario De Torrevieja

Study on the Use of Ursodeoxycholic Acid for Patients Undergoing Surgery for Retinal Detachment

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ursodeoxycholic Acid
  • Sponsor:Hospital Foch

Study on the Safety and Tolerability of STK-002 for Patients with Autosomal Dominant Optic Atrophy

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:18‐MER antisense oligonucleotide complementary to OPA1 PRE-mRNA
  • Sponsor:Stoke Therapeutics Inc.

Substances studied in this area

The therapies tested most often in Eye disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.